Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3674736011 | Mesalazine 250 mg rectal suppository | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | IPS terminology module (core metadata concept) |
| 3674738012 | Mesalamine 250 mg rectal suppository | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | IPS terminology module (core metadata concept) |
| 3674739016 | Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | IPS terminology module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Mesalazine 250 mg rectal suppository | Is a | Mesalazine only product | true | Inferred relationship | Some | ||
| Mesalazine 250 mg rectal suppository | Has manufactured dose form | Rectal suppository | true | Inferred relationship | Some | ||
| Mesalazine 250 mg rectal suppository | Has unit of presentation | Suppository (unit of presentation) | true | Inferred relationship | Some | ||
| Mesalazine 250 mg rectal suppository | Has basis of strength substance (attribute) | Mesalazine | true | Inferred relationship | Some | 1 | |
| Mesalazine 250 mg rectal suppository | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Mesalazine 250 mg rectal suppository | Has presentation strength denominator unit (attribute) | Suppository (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Mesalazine 250 mg rectal suppository | Has precise active ingredient | Mesalazine | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
FHIR